This could also be particularly relevant in cancer treatment, as it has been recently reported that inhibition of Vps34 reprograms cold into hot inflamed tumors, thus, improving anti-PD-1/PD-L1 immunotherapy in melanoma and colorectal cancer mouse models [59]. Here, PIK3C3 is linked to colorectal cancer.